Medical/Pharmaceuticals

Business Update on ASC10, an Oral Double Prodrug against COVID-19

HANGZHOU and SHAOXING, China, March 15, 2022 /PRNewswire/ -- Ascletis Pharma Inc. (HKEX: 1672) today announces the business update on its oral double prodrug ASC10 against Coronavirus Disease 2019 (COVID-19): By taking measures below, the manufacturing cost of ASC10 reduced significantly, which ...

2022-03-15 19:55 3968

Animal health company Emollivet raises capital and strengthens team

GOTHENBURG, Sweden, March 15, 2022 /PRNewswire/ -- Emollivet, the animal health company that develops user-friendly skin care products for animals, is raising capital and recruiting key people. The new share issue, a rights issue to existing owners, amounts toSEK 5 million. On 3rd March, Emolliv...

2022-03-15 15:48 2078

Sirnaomics to Present Latest Developments on its GalNAc-Based Liver-Targeting Platforms and Product Pipeline at the 2022 Oligonucleotide & Precision Therapeutics Congress

Sirnaomics CTO Dmitry Samarsky, PhD, to Also Present OPT Congress Opening Remarks HONG KONG, March 15, 2022 /PRNewswire/ -- Sirnaomics Ltd. ("Sirnaomics", stock code: 2257.HK), a leading biopharmaceutical company in discovery and development of RNAi therapeutics, announced today that it will pre...

2022-03-15 12:47 3710

Everest Medicines to Announce Full-Year 2021 Financial Results on March 29, 2022

SHANGHAI, March 15, 2022 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on developing and commercializing transformative pharmaceutical products to address critical unmet needs inAsia Pacific markets, today announced that it will...

2022-03-15 09:00 4278

European Wellness Biomedical Group and AK International to Bring Biological Regenerative Medicine Solutions to Pakistan and UAE

DUBAI, UAE, March 15, 2022 /PRNewswire/ -- European Wellness Biomedical Group (EWBG) has signed a Memorandum of Agreement (MOA) withDubai-based AK International LLC (AKI), partnering together to undertake a number of joint venture businesses inPakistan and the MENA region that focus on providing ...

2022-03-15 08:00 4034

SOPHiA GENETICS and REALM IDx Sign Letter of Intent to Collaborate in Accelerating Cancer Research

The intended collaboration aims to help improve patient care by enhancing next-generation sequencing research for cancer care and expanding data sources for precision medicine. BOSTON, ALISO VIEJO, Calif. and LAUSANNE, Switzerland, March 14, 2022 /PRNewswire/ -- SOPHiA GENETICS (Nasdaq: SOPH) an...

2022-03-14 20:28 3139

iGene Laboratory launches saliva-based COVID-19 PCR tests in Singapore

SINGAPORE, March 14, 2022 /PRNewswire/ -- In a move towards easing the uncomfortable nature of nasal swabs, a new saliva-based COVID-19 PCR test is now available at select iGene Laboratory partner clinics throughoutSingapore.

2022-03-14 16:39 3801

Guardant Health Receives Regulatory Approval for Guardant360 CDx in Japan

TOKYO, March 14, 2022 /PRNewswire/ -- The Ministry of Health, Labour and Welfare (MHLW) has granted regulatory approval of Guardant360® CDx, a liquid biopsy test for tumor mutation profiling, also known as comprehensive genomic profiling (CGP), in patients with advanced solid cancers. The Guardan...

2022-03-14 16:22 4852

SIFI Announces the Grant of a Second FDA Orphan Drug Designation for Polihexanide in Fungal Keratitis

This follows the previously-granted ODD for polihexanide in Acanthamoeba Keratitis by the FDA and EMA. An estimated 15,660 patients with fungal keratitis are diagnosed annually in the US. CATANIA, Italy, March 14, 2022 /PRNewswire/ -- SIFI S.p.A. ("SIFI" or the "Company"), a leading internationa...

2022-03-14 16:00 2924

Clarivate Deals Report Highlights Emerging Trends in Biopharma Deal-Making

RNA, cell & gene therapies, artificial intelligence, CRISPR and oncology related deals dominate the landscape Biotech companies in U.S. awarded largest sums of capital, followed by Mainland China and UK LONDON, March 14, 2022 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT), a global leader in provid...

2022-03-14 16:00 2727

Universiti Kebangsaan Malaysia Lecturer Finds a Potential Solution to Memory Loss

KUALA LUMPUR, Malaysia, March 14, 2022 /PRNewswire/ -- A Universiti Kebangsaan Malaysia (UKM) lecturer, Dr You Yee Xing has discovered the use of 'Cosmos Caudatus', which has been proven to be effective in preventing memory loss and increasing cognitive function among the elderly.

2022-03-14 10:00 3261

CStone announces the NMPA approval of GAVRETO (pralsetinib) for the treatment of Advanced or Metastatic RET-mutant medullary thyroid cancer and RET fusion-positive thyroid cancer

* GAVRETO is the first and only selective rearranged during transfection (RET) inhibitor approved inChina for the treatment of RET-mutant medullary thyroid cancer (MTC) and RET fusion-positive thyroid cancer (TC) * The labeled indications of GAVRETO have been expanded after it was approved by...

2022-03-14 08:05 4802

Everest Medicines Enters into Agreement with Calliditas Therapeutics, Expanding Territory License to Develop and Commercialize NEFECON in South Korea

SHANGHAI, March 14, 2022 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK), a biopharmaceutical company focused on developing and commercializing transformative pharmaceutical products to address critical unmet needs inAsia Pacific markets, announced today that...

2022-03-14 08:00 5317

Latest Study Shows Advantages of CanSinoBIO's Convidecia™ as Heterologous Booster against Omicron Variant

TIANJIN, China, March 14, 2022 /PRNewswire/ -- CanSino Biologics Inc. ("CanSinoBIO") (SSE: 688185, HKEX: 06185) today announced that medRxiv, a preprint platform for preliminary biomedical research, published an academic paper1 on the efficacy of CanSinoBIO's Recombinant COVID-19 Vaccine ("Ad5-n...

2022-03-14 08:00 3886

Ascletis Announces Further Expansion of Ritonavir Oral Tablet Production Capacity to 530 Million Tablets Per Year

HANGZHOU, China and SHAOXING, China, March 13, 2022 /PRNewswire/ -- Ascletis Pharma Inc. (Ascletis, HKEX: 1672) today announces that it has further expanded its ritonavir oral tablet production capacity to approximately 530 million tablets per year, to meet the potential escalation in the domesti...

2022-03-13 18:30 5101

Terran Biosciences announces acquisition of a portfolio of novel CNS therapeutics from Concert Pharmaceuticals

NEW YORK, March 11, 2022 /PRNewswire/ -- Terran Biosciences ("Terran"), a biotech platform company dedicated to the development of transformational therapeutics for neurological and psychiatric diseases, has entered into an agreement with Concert Pharmaceuticals ("Concert") to acquire a portfolio...

2022-03-11 21:38 9240

NMPA Clears IND for First T-Cell Receptor (TCR) T Cell Therapy to Treat Hepatitis B virus (HBV) associated hepatocellular carcinoma (HCC)

SINGAPORE, March 11, 2022 /PRNewswire/ -- Singapore-based SCG Cell Therapy Pte Ltd ("SCG"), a leading biotechnology company, today announced that the China National Medical Products Administration (NMPA) has cleared its Investigational New Drug (IND) application for SCG101, the company's first T-...

2022-03-11 21:07 5648

Biobot Surgical signs MOU with BEBIG Medical to collaborate on a robotic-guided prostate brachytherapy solution

SINGAPORE, March 11, 2022 /PRNewswire/ -- Biobot Surgical, a robotic-assisted percutaneous surgical systems company, is delighted to announce a MOU with BEBIG Medical, a global provider of radiotherapy products and a brachytherapy leader based inEurope to work together to provide a robotic-guided...

2022-03-11 13:00 3472

Biobot Surgical signs MOU with BEBIG Medical to collaborate on a robotic-guided prostate brachytherapy solution

SINGAPORE, March 11, 2022 /PRNewswire/ -- Biobot Surgical, a robotic-assisted percutaneous surgical systems company, is delighted to announce a MOU with BEBIG Medical, a global provider of radiotherapy products and a brachytherapy leader based inEurope to work together to provide a robotic-guided...

2022-03-11 13:00 3341

ALEA LAUNCHES "ALEA FOR WOMEN"

HONG KONG, March 11, 2022 /PRNewswire/ -- Women account for 80% of purchasing decisions in the healthcare industry. Yet, too few insurance solutions are focused on their specific needs. Moreover, when it comes to women's health, available resources and information are often lacking or difficult t...

2022-03-11 11:00 3937
1 ... 341342343344345346347 ... 380